researched 72 / 72 ・ last checked 2026-09-23 ENJA
Japan8United States8Canada8European Union8United Kingdom8China8Australia8Korea8Switzerland8

Advertising Atlas ／ China ／ Safety information

Safety information

China ／ NMPA

A drug advertisement must prominently state the contraindications and the adverse reactions.

医薬品広告には禁忌および副作用（不良反応）を目立つ形で明示しなければならない。

statuteAdvertising Law of the People's Republic of China (as amended 2021), article 16 paragraph 2checked 2026-09-23
Note
Repeated in SAMR Order No. 21 article 5, verified at https://sjfg.samr.gov.cn/law/file/pdf/3235243/1663660163213.pdf

The same topic elsewhere

Japan ── In sales information provision activities a company must provide necessary saf…United States ── Every prescription drug advertisement other than the listed exempt advertiseme…Canada ── Risk information must be given prominence comparable to benefit in the main bo…European Union ── Advertising to persons qualified to prescribe or supply must include essential…United Kingdom ── An advertisement directed at persons qualified to prescribe or supply must inc…Australia ── An advertisement about therapeutic goods must not contain any statement, picto…Korea ── For a drug that has adverse reactions, no advertisement may use expressions th…Switzerland ── Every advertisement must contain at least a summary of the restrictions on use…
Every cell carries a summary, a source and a date checked. Topics whose source has not been verified are left marked “not researched” rather than filled with plausible text. Directives and statutes bind as to the result; what applies in practice is national implementing law. This is a research aid, not legal advice.